BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 17, 2014
View Archived Issues
Novel antiviral drugs demonstrate efficacy against diverse RNA and DNA viral pathogens
Read More
Update on phase I trial of AG-221, a potent IDH2 mutant protein inhibitor
Read More
Fibrocell and Intrexon's epidermolysis bullosa cell therapy receives U.S. orphan drug status
Read More
Novel agents for parasitic diseases designed by IRM and Novartis
Read More
[18F]-GP1: a potential a PET tracer for thrombi in humans
Read More
PSMA ligand evaluated in patients for the diagnosis of prostate cancer
Read More
Novel PIKfyve inhibitor described by Astellas scientists
Read More
University of Cape Town discloses agents for tuberculosis
Read More
Biofordrug designs novel 5-HT7 receptor ligands
Read More
DiscoveryBiomed presents novel CFTR correctors for cystic fibrosis
Read More
GlaxoSmithKline divulges new DGAT1 inhibitors
Read More
New agents for allergic diseases designed at GlaxoSmithKline
Read More
New Omega-3 fatty acid analogues disclosed by the University of Sydney
Read More
Phase I data reported for Themis Bioscience's vaccine against Chikungunya fever
Read More
Aastom Biosciences outlines strategic plans for cell therapy and regenerative medicine business
Read More
Torii Pharmaceutical reports results from Japanese trials of house dust mite SLIT tablet
Read More
Rucaparib enters phase II trial in BRCA-mutant pancreatic cancer
Read More
Medtronic to acquire Covidien
Read More
FDA grants orphan drug designation to AG-221 for AML
Read More
Dainippon Sumitomo Pharma closes further enrollment in phase III colorectal cancer study
Read More
FDA and EMA accept applications for AbbVie's HCV regimen
Read More
Kringle initiates Japanese study of rhHGF in acute spinal cord injury
Read More
BL-8040 to be evaluated for stem cell mobilization in phase I trial
Read More
Vedolizumab enters U.S. market for ulcerative colitis and Crohn's disease
Read More
Convergence reports positive phase II data for sodium channel blocker analgesic
Read More
Gilead Sciences reports data from phase III study of ledipasvir/sofosbuvir in Japanese patients
Read More